Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients - Concepedia

Concepedia

Publication | Closed Access

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

737

Citations

14

References

1996

Year

Turid Aas, Anne‐Lise Børresen, Stephanie Geisler, Birgitte Smith‐Sørensen, Hilde Johnsen, Jan Erik Varhaug, Lars A. Akslen, Per Eystein Lønning

Nature Medicine

Breast OncologyBreast Cancer PatientsMedicinePathologyCancer GenomicsCancer BiologyBreast CancerSpecific P53 MutationsCancer GeneticsOncologyRadiation OncologyTumor Biology

References

	Year	Citations

Page 1

Page 1